Press release
Transcatheter Pulmonary Valve (TPV) Market to be at Forefront by 2025
Report Overview @ https://www.persistencemarketresearch.com/market-research/transcatheter-pulmonary-valve-market.asp
Transcatheter pulmonary valve used in patients born with heart defects, who is having failing conduit. Transcatheter pulmonary valve helps patients to delay the time when a patient needs additional open heart surgery. Transcatheter pulmonary valve also reduces the total number of open heart surgeries a patient needs in life time.
Transcatheter Pulmonary Valve (TPV) market is driven by increasing prevalence of comorbidities like diabetes and cardiovascular diseases coupled with increasing incidence of Congestive Heart Diseases (CHD) among varied patient age groups. Transcatheter pulmonary valve mainly indicated for extension of functional life of RV-PA conduit, for restoring pulmonary valve competence, and for relieving conduit stenosis without inducing regurgitation in patients which makes the transcatheter pulmonary valve market lucrative over the forecast period.
In addition, valves effectives in prolonging the open heart surgeries backed with robust clinical effectiveness in three clinical trials is expected to boost the revenue growth of transcatheter pulmonary valve market over the forecast period. However, low target population for therapy and snail pace adoption in both developing and developed economies expected to may impact the transcatheter pulmonary valve market revenue growth negatively over the forecast period.
Request Report for TOC @ https://www.persistencemarketresearch.com/toc/14152
Transcatheter Pulmonary Valve (TPV) market is undergoing market changes due to promising clinical development of newer technologies in the pipeline and increasing demand for minimally invasice therapies among healthcare fraternity and patient groups. The first Transcatheter Pulmonary Valve (TPV) was introduced by Medtronic plc in 2010 under a Humanitarian Device Exemption (HDE), a regulatory approval for treatments intended for fewer than 4,000 U.S. patients per year. Later in 2015, Medtronic plc received Pre-Market Approval (PMA) from U.S. regulator Food and Drug Administration (FDA) company’s device Melody based on significant clinical evidence from three clinical trials.
Geographically, Transcatheter Pulmonary Valve (TPV) market is segmented into regions viz. North America, Latin America, Europe, Asia Pacific and Japan, Middle East and Africa. North America and Europe region is projected to maintain its lions share over the forecast period. Advanced healthcare infrastructure, availability well equipped healthcare professionals is expected to propel the demand for Transcatheter Pulmonary Valve (TPV) during the forecast period in the above mentioned region. Asia Pacific region is expected to be the moderately growing regional market. Growing healthcare facilities, increased healthcare awareness, and conducive regulatory environment are mainly generating the demand for Transcatheter Pulmonary Valve (TPV) in the region.
The players in Transcatheter Pulmonary Valve (TPV) market include Medtronic plc., Edwards Lifesciences Corporation, VENUS MEDTECH etc.
Request to Sample of Report @ https://www.persistencemarketresearch.com/samples/14152
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Transcatheter Pulmonary Valve (TPV) Market to be at Forefront by 2025 here
News-ID: 908120 • Views: …
More Releases from Persistence Market Research
Aseptic Packaging Market Set to Grow to US$136.5 Bn by 2033 Driven by Rising Foo …
Introduction: Aseptic Packaging Market Overview and Industry Evolution
The aseptic packaging market has emerged as a cornerstone of modern food, beverage, and pharmaceutical preservation systems. As global consumers increasingly seek safe, long-lasting, and convenient packaged products, aseptic packaging solutions have gained substantial importance. This technology allows products to be sterilized separately from packaging materials and filled in a sterile environment, ensuring extended shelf life without refrigeration or preservatives. The rising demand…
Gas-Insulated Transmission Line (GIL) Market Expected to See Growth to US$836.9 …
Introduction: Rising Demand for Advanced Power Transmission Solutions
The global energy landscape is undergoing a major transformation as nations accelerate investments in renewable energy, grid expansion, and reliable electricity distribution networks. With rapid urbanization, industrialization, and digital infrastructure growth, the demand for uninterrupted and efficient power transmission has never been higher. Traditional overhead transmission systems, while widely used, face challenges related to land constraints, environmental exposure, and transmission losses. This has…
Dimethyl Sulfide (DMS) Market Anticipated to Reach US$ 251.2 Mn by 2033, Driven …
Market Overview: Expanding Demand for Dimethyl Sulfide Across Industries
The Dimethyl Sulfide (DMS) market is witnessing consistent growth due to its widespread applications across food processing, pharmaceuticals, agriculture, and chemical manufacturing. Dimethyl sulfide is an organosulfur compound known for its distinctive odor and reactive properties, making it a crucial intermediate in multiple industrial processes. In food and beverage applications, it is valued for flavor enhancement, while in chemical manufacturing, it serves…
Onyx Stone Market to Surge to Reach US$ 1.8 Bn by 2033 Driven by Construction & …
Market Overview: Rising Demand for Premium Natural Stones
The onyx stone market has gained remarkable prominence in recent years, driven by increasing demand for luxury natural stones in architecture, interior décor, and artistic applications. Onyx, known for its translucent appearance and unique veining patterns, has become a preferred choice for premium residential and commercial projects. The material's ability to elevate aesthetic appeal while maintaining durability has attracted designers, architects, and homeowners…
More Releases for Transcatheter
Transcatheter Aortic Valve Replacement Market Trends That Will Shape the Next De …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Transcatheter Aortic Valve Replacement Market Size By 2025?
The market for transcatheter aortic valve replacement has been increasing at a swift pace in the past few years. It's expected to escalate from $5.19 billion in 2024, reaching $5.87 billion in 2025, with a compound annual…
Major Market Shift in Transcatheter Embolization And Occlusion Devices Industry: …
What Is the Forecasted Market Size and Growth Rate for the Transcatheter Embolization And Occlusion Devices Market?
The market size of transcatheter embolization and occlusion devices has seen swift expansion in recent years. It is predicted to escalate from $4.76 billion in 2024 to $5.28 billion in 2025, with a compound annual growth rate (CAGR) of 10.9%. The surge during the historic era can be ascribed to the expansion in…
Transcatheter Heart Valve Replacement Market Forecast Report By Type (Transcathe …
Global Transcatheter Heart Valve Replacement Market
The global Transcatheter Heart Valve Replacement (THVR) market is poised for significant growth, with projections indicating an expansion from US$6.34 billion in 2023 to US$17.58 billion by 2032. This represents a robust compound annual growth rate (CAGR) of 11.99% from 2024 to 2032. The market's growth is primarily driven by an aging population, increasing prevalence of cardiovascular diseases, and advancements in minimally invasive procedures.
Transcatheter Heart…
Transcatheter Pacing System Market Size 2024 to 2031.
Market Overview and Report Coverage
Transcatheter Pacing System, also known as leadless pacemakers, are advanced medical devices used to regulate heart rhythm in patients with cardiac arrhythmias. These devices are implanted directly into the heart without the need for traditional pacing leads.
The future outlook for the Transcatheter Pacing System Market is promising, with a projected CAGR of 9.80% during the forecasted period. This growth can be attributed to the…
Transcatheter Heart Valve Replacement Repair Market
The Transcatheter Heart Valve Replacement Repair Market is expected to grow on an unabashed note in the next decade. With a worldwide shortage of healthcare staff, the healthcare IT solutions comprising web-based staffing platforms are doing the rounds. The future scenario won't be any different. These platforms would show the gaps, i.e. actual dearth of healthcare personnel like nurse's doctors, technicians, lab workers, and clinicians, which would help the entire…
Recent Study on Transcatheter Valve Market: 2019-2026 Global Industry Key Compan …
The Global Transcatheter Valve Market is high risk of complications from surgical aortic valve replacement is driving the growth of the market. However, high risk of blood vessel tearing yet remains major restraints to the market.
Get Sample copy @ https://www.orianresearch.com/request-sample/1099645
Key players profiled in the report includes: Boston Scientific Corporation, Direct Flow medical, Edwards Lifesciences Corporation, HLT, JenaValve Technology, Medtronic plc, Meril Life Sciences Pvt. Ltd., St. Jude Medical, SYMETIS…
